NCT06033183Recruiting
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
Source: ClinicalTrials.gov · Last updated 22 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Analysis of the individual radiosensitivity in pediatric oncology
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 25 Aug 2023
- Start date
- 2 Dec 2023
- Primary completion date
- 30 Aug 2027
- Lead sponsor
- Neolys
- Diseases
- Childhood cancers
- NCT number
- NCT06033183
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 2 Dec 2023 to the primary completion date, 30 Aug 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with contraindications to radiotherapy
- Palliative radiotherapy
- Patient with previous RT treatment in the same area (re-irradiation)
Other
- Patients with contraindications to blood sampling
- Patient with an indication of hypofractionated RT
- Patient follow-up not possible
- Persons deprived of liberty or under guardianship (including curatorship)
- \-
Who the study is looking for
- Minor patient treated for a brain tumor, Ewing tumor, malignant mesenchymal tumor, neuroblastoma, nephroblastoma, Hodgkin's lymphoma treated with radiotherapy (+/- chemotherapy) for curative purposes.
- Children or adolescents \> 3 years old and \< 18 years old
- Patient with an indication for radiotherapy as part of the primary tumor local control strategy
- Theoretical indication for radiotherapy in standard fractionation (1.8 Gy to 2.2 Gy / fraction: 5 fr/week) whatever the technique and the particle used
- Patient affiliated with a social security scheme
- Patient and/or parents or holders of parental authority having dated and signed an informed consent
Age in the registry: 3 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre François Baclesse Coordinator of this site? Confirm its status | Caen | France | Recruiting |
| Centre Oscar Lambret Coordinator of this site? Confirm its status | Lille | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.